IRadimed Corporation
IRMD
$51.37
-$0.915-1.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.51M | 19.39M | 18.33M | 17.93M | 17.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.51M | 19.39M | 18.33M | 17.93M | 17.60M |
| Cost of Revenue | 4.67M | 4.63M | 4.13M | 3.92M | 4.21M |
| Gross Profit | 14.84M | 14.76M | 14.19M | 14.01M | 13.39M |
| SG&A Expenses | 8.80M | 8.40M | 7.77M | 7.59M | 7.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.08M | 13.59M | 12.54M | 12.30M | 12.85M |
| Operating Income | 5.43M | 5.80M | 5.79M | 5.63M | 4.75M |
| Income Before Tax | 5.95M | 6.34M | 6.42M | 6.27M | 5.24M |
| Income Tax Expenses | 1.26M | 1.20M | 1.37M | 1.37M | 1.11M |
| Earnings from Continuing Operations | 4.69M | 5.15M | 5.05M | 4.90M | 4.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.69M | 5.15M | 5.05M | 4.90M | 4.14M |
| EBIT | 5.43M | 5.80M | 5.79M | 5.63M | 4.75M |
| EBITDA | 5.63M | 6.00M | 5.99M | 5.83M | 4.97M |
| EPS Basic | 0.37 | 0.41 | 0.40 | 0.39 | 0.33 |
| Normalized Basic EPS | 0.29 | 0.31 | 0.32 | 0.31 | 0.26 |
| EPS Diluted | 0.37 | 0.40 | 0.40 | 0.38 | 0.32 |
| Normalized Diluted EPS | 0.29 | 0.31 | 0.31 | 0.31 | 0.26 |
| Average Basic Shares Outstanding | 12.71M | 12.68M | 12.67M | 12.66M | 12.66M |
| Average Diluted Shares Outstanding | 12.83M | 12.81M | 12.78M | 12.76M | 12.75M |
| Dividend Per Share | 0.17 | 0.17 | 0.15 | 0.15 | -- |
| Payout Ratio | 46.11% | 36.94% | 37.64% | 38.76% | 192.82% |